Literature DB >> 21416193

The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome).

Elke Miebach1, Heather Church, Alan Cooper, Jean Mercer, Karen Tylee, Robert F Wynn, J Edmond Wraith.   

Abstract

Mucopolysaccharidosis I Hurler (MPS IH) is a progressive multisystemic disorder caused by alpha-L-iduronidase deficiency. First choice of treatment in MPS IH children is haematopoietic stem cell transplantation (HSCT). The effect of HSCT has been shown to have limited influence on skeletal manifestations by poor penetration of musculoskeletal tissues by the enzyme derived from donor leucocytes. Aim of this study was to investigate the effect of HSCT on the craniocervical junction (CCJ) in Hurler patients. We analysed retrospectively sequential magnetic resonance imaging (MRI) scans of 30 patients with Hurler disease treated by HSCT since 1982 at the Royal Manchester Children's Hospital, UK, in order to determine whether the patients suffer from dens hypoplasia. Results were compared with biochemical and clinical characteristics: Enzyme activity (EA), chimerism, urinary glycosaminoglycan (GAG) excretion and neurological status. Investigations were part of standard clinical procedures. Results are descriptive in presentation. In 26/30 patients a determination of odontoid hypoplasia was feasible. The majority showed a normal dens length and an increase with age. Only 3/26 revealed a dens hypoplasia. One of them had only partial donor engraftment (DE) with reduced EA, one of them suffered from chronic graft versus host disease (GVHD). One patient with only partial DE and reduced EA presented with initial dens hypoplasia until preadolescence but normalized later on. There may be a trend towards lower EA and the occurrence of DH in transplanted MPS patients - perhaps the dosage of enzyme plays a role in the correction of skeletal complications in this patient group. HSCT patients with incomplete DE and therefore lower EAs may require special attention and care.

Entities:  

Mesh:

Year:  2011        PMID: 21416193     DOI: 10.1007/s10545-011-9309-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

1.  Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation.

Authors:  Jason S Weisstein; Eliana Delgado; Lynne S Steinbach; Kim Hart; Seymour Packman
Journal:  J Pediatr Orthop       Date:  2004 Jan-Feb       Impact factor: 2.324

Review 2.  The clinical outcome of Hurler syndrome after stem cell transplantation.

Authors:  Mieke Aldenhoven; Jaap Jan Boelens; Tom J de Koning
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

3.  Radiological evaluation of the spinal cord in congenital atlanto-axial dislocation.

Authors:  M N Perovic; S E Kopits; R C Thompson
Journal:  Radiology       Date:  1973-12       Impact factor: 11.105

4.  Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H).

Authors:  S H Hite; C Peters; W Krivit
Journal:  Pediatr Radiol       Date:  2000-07

5.  Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.

Authors:  J Cox-Brinkman; J-J Boelens; J E Wraith; A O'meara; P Veys; F A Wijburg; N Wulffraat; R F Wynn
Journal:  Bone Marrow Transplant       Date:  2006-05-22       Impact factor: 5.483

6.  The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.

Authors:  Gregory M Pastores; Pamela Arn; Michael Beck; Joe T R Clarke; Nathalie Guffon; Paige Kaplan; Joseph Muenzer; Denise Y J Norato; Elsa Shapiro; Janet Thomas; David Viskochil; J Edmond Wraith
Journal:  Mol Genet Metab       Date:  2007-03-02       Impact factor: 4.797

7.  Spinal problems in mucopolysaccharidosis I (Hurler syndrome).

Authors:  V Tandon; J B Williamson; R A Cowie; J E Wraith
Journal:  J Bone Joint Surg Br       Date:  1996-11

8.  Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development.

Authors:  R E Field; J A Buchanan; M G Copplemans; P M Aichroth
Journal:  J Bone Joint Surg Br       Date:  1994-11

9.  Uptake of a recombinant human alpha-L-iduronidase (laronidase) by cultured fibroblasts and osteoblasts.

Authors:  Takahiro Tsukimura; Youichi Tajima; Ikuo Kawashima; Tomoko Fukushige; Tamotsu Kanzaki; Takuro Kanekura; Masahiko Ikekita; Kanako Sugawara; Toshihiro Suzuki; Tadayasu Togawa; Hitoshi Sakuraba
Journal:  Biol Pharm Bull       Date:  2008-09       Impact factor: 2.233

10.  Follow-up of nine patients with Hurler syndrome after bone marrow transplantation.

Authors:  N Guffon; G Souillet; I Maire; J Straczek; P Guibaud
Journal:  J Pediatr       Date:  1998-07       Impact factor: 4.406

View more
  12 in total

1.  Prevalence and development of orthopaedic symptoms in the dutch hurler patient population after haematopoietic stem cell transplantation.

Authors:  F J Stoop; M C Kruyt; M H van der Linden; R J B Sakkers; P M van Hasselt; R M C Castelein
Journal:  JIMD Rep       Date:  2012-09-19

Review 2.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 3.  Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.

Authors:  Brigitte T A van den Broek; Jaap van Doorn; Charlotte V Hegeman; Stefan Nierkens; Caroline A Lindemans; Nanda Verhoeven-Duif; Jaap Jan Boelens; Peter M van Hasselt
Journal:  Blood Adv       Date:  2020-06-23

Review 4.  Spinal involvement in mucopolysaccharidoses: a review.

Authors:  Antonio Leone; Donato Rigante; Daniele Zaccaria Amato; Roberto Casale; Luigi Pedone; Nicola Magarelli; Cesare Colosimo
Journal:  Childs Nerv Syst       Date:  2014-10-31       Impact factor: 1.475

5.  Surgical management of thoracolumbar kyphosis in mucopolysaccharidosis type 1 in a reference center.

Authors:  Kariman Abelin Genevois; Christophe Garin; Federico Solla; Nathalie Guffon; Rémi Kohler
Journal:  J Inherit Metab Dis       Date:  2013-06-29       Impact factor: 4.982

6.  Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs.

Authors:  Joseph A Chiaro; Patricia O'Donnell; Eileen M Shore; Neil R Malhotra; Katherine P Ponder; Mark E Haskins; Lachlan J Smith
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

Review 7.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

8.  Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs.

Authors:  Joseph A Chiaro; Matthew D Baron; Chelsea M Del Alcazar; Patricia O'Donnell; Eileen M Shore; Dawn M Elliott; Katherine P Ponder; Mark E Haskins; Lachlan J Smith
Journal:  Bone       Date:  2013-04-04       Impact factor: 4.398

9.  Molecular Genetics and Metabolism Report Long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements.

Authors:  Eriko Yasuda; William Mackenzie; Kristen Ruhnke; Tsutomu Shimada; Robert W Mason; Jozef Zustin; Paul L Martin; Mihir Thacker; Tadao Orii; Yoshimichi Sai; Shunji Tomatsu
Journal:  Mol Genet Metab Rep       Date:  2015-03

10.  Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.

Authors:  Mona Schmidt; Sandra Breyer; Ulrike Löbel; Sinef Yarar; Ralf Stücker; Kurt Ullrich; Ingo Müller; Nicole Muschol
Journal:  Orphanet J Rare Dis       Date:  2016-07-08       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.